{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:22:21Z","timestamp":1790504541833,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T00:00:00Z","timestamp":1438819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T00:00:00Z","timestamp":1438819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Autophagy can sustain or kill tumor cells depending upon the context. The mechanism of autophagy-associated cell death has not been well elucidated and autophagy has enhanced or inhibited sensitivity of cancer cells to cytotoxic chemotherapy in different models. <jats:italic>ARHI<\/jats:italic> (<jats:italic>DIRAS3<\/jats:italic>), an imprinted tumor suppressor gene, is downregulated in 60% of ovarian cancers. In cell culture, re-expression of ARHI induces autophagy and ovarian cancer cell death within 72\u2009h. In xenografts, re-expression of ARHI arrests cell growth and induces autophagy, but does not kill engrafted cancer cells. When ARHI levels are reduced after 6 weeks, dormancy is broken and xenografts grow promptly. In this study, ARHI-induced ovarian cancer cell death in culture has been found to depend upon autophagy and has been linked to G1 cell-cycle arrest, enhanced reactive oxygen species (ROS) activity, RIP1\/RIP3 activation and necrosis. Re-expression of ARHI enhanced the cytotoxic effect of cisplatin in cell culture, increasing caspase-3 activation and PARP cleavage by inhibiting ERK and HER2 activity and downregulating XIAP and Bcl-2. In xenografts, treatment with cisplatin significantly slowed the outgrowth of dormant autophagic cells after reduction of ARHI, but the addition of chloroquine did not further inhibit xenograft outgrowth. Taken together, we have found that autophagy-associated cancer cell death and autophagy-enhanced sensitivity to cisplatin depend upon different mechanisms and that dormant, autophagic cancer cells are still vulnerable to cisplatin-based chemotherapy.<\/jats:p>","DOI":"10.1038\/cddis.2015.208","type":"journal-article","created":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T15:49:19Z","timestamp":1438876159000},"page":"e1836-e1836","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts"],"prefix":"10.1038","volume":"6","author":[{"given":"M N","family":"Washington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A F","family":"Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M N","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Millward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ornelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"R C","family":"Bast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,6]]},"reference":[{"key":"BFcddis2015208_CR1","doi-asserted-by":"publisher","first-page":"R282","DOI":"10.1016\/j.cub.2005.04.013","volume":"15","author":"DJ Klionsky","year":"2005","unstructured":"Klionsky DJ . Autophagy. Curr Biol 2005; 15: R282\u2013R283.","journal-title":"Curr Biol"},{"key":"BFcddis2015208_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cdd.2008.139","volume":"16","author":"B Levine","year":"2009","unstructured":"Levine B, Kroemer G . Autophagy in aging, disease and death: the true identity of a cell death impostor. Cell Death Differ 2009; 16: 1\u20132.","journal-title":"Cell Death Differ"},{"key":"BFcddis2015208_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2174\/18715273113126660189","volume":"13","author":"SM Fayaz","year":"2014","unstructured":"Fayaz SM, Suvanish Kumar VS, Rajanikant GK . Necroptosis: who knew there were so many interesting ways to die? CNS Neurol Disord Drug Targets 2014; 13: 42\u201351.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"BFcddis2015208_CR4","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1084\/jem.20110251","volume":"208","author":"IL Ch'en","year":"2011","unstructured":"Ch'en IL, Tsau JS, Molkentin JD, Komatsu M, Hedrick SM . Mechanisms of necroptosis in T cells. J Exp Med 2011; 208: 633\u2013641.","journal-title":"J Exp Med"},{"key":"BFcddis2015208_CR5","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/45257","volume":"402","author":"XH Liang","year":"1999","unstructured":"Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999; 402: 672\u2013676.","journal-title":"Nature"},{"key":"BFcddis2015208_CR6","doi-asserted-by":"publisher","first-page":"15077","DOI":"10.1073\/pnas.2436255100","volume":"100","author":"Z Yue","year":"2003","unstructured":"Yue Z, Jin S, Yang C, Levine AJ, Heintz N . Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA 2003; 100: 15077\u201315082.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2015208_CR7","doi-asserted-by":"publisher","first-page":"40002","DOI":"10.1074\/jbc.M111.297432","volume":"286","author":"S Huang","year":"2011","unstructured":"Huang S, Yang ZJ, Yu C, Sinicrope FA . Inhibition of mTOR kinase by AZD8055 can antagonize chemotherapy-induced cell death through autophagy induction and down-regulation of p62\/sequestosome 1. J Biol Chem 2011; 286: 40002\u201340012.","journal-title":"J Biol Chem"},{"key":"BFcddis2015208_CR8","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1111\/j.1742-4658.2009.07332.x","volume":"276","author":"EA Corcelle","year":"2009","unstructured":"Corcelle EA, Puustinen P, Jaattela M . Apoptosis and autophagy: targeting autophagy signalling in cancer cells -'trick or treats'? FEBS J 2009; 276: 6084\u20136096.","journal-title":"FEBS J"},{"key":"BFcddis2015208_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00726-011-1167-9","volume":"44","author":"A Budillon","year":"2013","unstructured":"Budillon A, Carbone C, Di Gennaro E . Tissue transglutaminase: a new target to reverse cancer drug resistance. Amino Acids 2013; 44: 63\u201372.","journal-title":"Amino Acids"},{"key":"BFcddis2015208_CR10","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.4155\/fmc.13.85","volume":"5","author":"F Aredia","year":"2013","unstructured":"Aredia F, Scovassi AI . Manipulation of autophagy in cancer cells: an innovative strategy to fight drug resistance. Future Med Chem 2013; 5: 1009\u20131021.","journal-title":"Future Med Chem"},{"key":"BFcddis2015208_CR11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000048259","volume":"62","author":"H Hisatomi","year":"2002","unstructured":"Hisatomi H, Nagao K, Wakita K, Kohno N . ARHI\/NOEY2 inactivation may be important in breast tumor pathogenesis. Oncology 2002; 62: 136\u2013140.","journal-title":"Oncology"},{"issue":"3","key":"BFcddis2015208_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1042\/BSR20090008","volume":"30","author":"S Huang","year":"2010","unstructured":"Huang S, Chang IS, Lin W, Ye W, Luo RZ, Lu Z et al. ARHI (DIRAS3), an imprinted tumour suppressor gene, binds to importins and blocks nuclear import of cargo proteins. Biosci Rep 2010; 30 (3): 159\u2013168.","journal-title":"Biosci Rep"},{"key":"BFcddis2015208_CR13","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1038\/sj.onc.1206380","volume":"22","author":"RZ Luo","year":"2003","unstructured":"Luo RZ, Fang X, Marquez R, Liu SY, Mills GB, Liao WS et al. ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers. Oncogene 2003; 22: 2897\u20132909.","journal-title":"Oncogene"},{"key":"BFcddis2015208_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/onc.2011.213","volume":"31","author":"DB Badgwell","year":"2011","unstructured":"Badgwell DB, Lu Z, Le K, Gao F, Yang M, Suh GK et al. The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK\/Rho signaling pathways. Oncogene 2011; 31: 68\u201379.","journal-title":"Oncogene"},{"key":"BFcddis2015208_CR15","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/cdd.2014.48","volume":"21","author":"Z Lu","year":"2014","unstructured":"Lu Z, Yang H, Sutton MN, Yang M, Clarke CH, Liao WS et al. ARHI (DIRAS3) induces autophagy in ovarian cancer cells by downregulating the epidermal growth factor receptor, inhibiting PI3K and Ras\/MAP signaling and activating the FOXo3a-mediated induction of Rab7. Cell Death Differ 2014; 21: 1275\u20131289.","journal-title":"Cell Death Differ"},{"key":"BFcddis2015208_CR16","first-page":"3917","volume":"118","author":"Z Lu","year":"2008","unstructured":"Lu Z, Luo RZ, Lu Y, Zhang X, Yu Q, Khare S et al. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J Clin Invest 2008; 118: 3917\u20133929.","journal-title":"J Clin Invest"},{"key":"BFcddis2015208_CR17","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/cncr.23323","volume":"112","author":"W Feng","year":"2008","unstructured":"Feng W, Marquez RT, Lu Z, Liu J, Lu KH, Issa JP et al. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Cancer 2008; 112: 1489\u20131502.","journal-title":"Cancer"},{"key":"BFcddis2015208_CR18","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/sj.onc.1209025","volume":"25","author":"Z Lu","year":"2006","unstructured":"Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK et al. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer. Oncogene 2006; 25: 230\u2013239.","journal-title":"Oncogene"},{"key":"BFcddis2015208_CR19","doi-asserted-by":"publisher","first-page":"6559","DOI":"10.1158\/1078-0432.CCR-04-0698","volume":"10","author":"DG Rosen","year":"2004","unstructured":"Rosen DG, Wang L, Jain AN, Lu KH, Luo RZ, Yu Y et al. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1\/CIP1 and prolonged progression-free survival. Clin Cancer Res 2004; 10: 6559\u20136566.","journal-title":"Clin Cancer Res"},{"key":"BFcddis2015208_CR20","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.4161\/auto.28577","volume":"10","author":"Z Lu","year":"2014","unstructured":"Lu Z, Baquero MT, Yang H, Yang M, Reger AS, Kim C et al. DIRAS3 regulates the autophagosome initiation complex in dormant ovarian cancer cells. Autophagy 2014; 10: 1071\u20131092.","journal-title":"Autophagy"},{"key":"BFcddis2015208_CR21","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc2644","volume":"9","author":"RC Bast Jr","year":"2009","unstructured":"Bast RC Jr, Hennessy B, Mills GB . The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer 2009; 9: 415\u2013428.","journal-title":"Nat Rev Cancer"},{"issue":"Suppl 1","key":"BFcddis2015208_CR22","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1097\/IGC.0b013e318251c97d","volume":"22","author":"RC Bast Jr","year":"2012","unstructured":"Bast RC Jr, Skates S, Lokshin A, Moore RG . Differential diagnosis of a pelvic mass: improved algorithms and novel biomarkers. Int J Gynecol Cancer 2012; 22 (Suppl 1): S5\u2013S8.","journal-title":"Int J Gynecol Cancer"},{"key":"BFcddis2015208_CR23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1158\/1078-0432.CCR-12-1045","volume":"19","author":"AJ Ziebarth","year":"2013","unstructured":"Ziebarth AJ, Nowsheen S, Steg AD, Shah MM, Katre AA, Dobbin ZC et al. Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer. Clin Cancer Res 2013; 19: 170\u2013182.","journal-title":"Clin Cancer Res"},{"key":"BFcddis2015208_CR24","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.2174\/1566524013666131111125515","volume":"13","author":"X Chen","year":"2013","unstructured":"Chen X, Wu Y, Dong H, Zhang CY, Zhang Y . Platinum-based agents for individualized cancer treatment. Curr Mol Med 2013; 13: 1603\u20131612.","journal-title":"Curr Mol Med"},{"key":"BFcddis2015208_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/IGC.0000000000000014","volume":"24","author":"H Itamochi","year":"2014","unstructured":"Itamochi H, Nishimura M, Oumi N, Kato M, Oishi T, Shimada M et al. Checkpoint kinase inhibitor AZD7762 overcomes cisplatin resistance in clear cell carcinoma of the ovary. Int J Gynecol Cancer 2014; 24: 61\u201369.","journal-title":"Int J Gynecol Cancer"},{"key":"BFcddis2015208_CR26","first-page":"527","volume":"137","author":"J Zhang","year":"2013","unstructured":"Zhang J, Kan Y, Tian Y, Wang Z, Zhang J . Effects of poly (ADP-ribosyl) polymerase (PARP) inhibitor on cisplatin resistance & proliferation of the ovarian cancer C13* cells. Indian J Med Res 2013; 137: 527\u2013532.","journal-title":"Indian J Med Res"},{"key":"BFcddis2015208_CR27","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1073\/pnas.96.1.214","volume":"96","author":"Y Yu","year":"1999","unstructured":"Yu Y, Xu F, Peng H, Fang X, Zhao S, Li Y et al. NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc Natl Acad Sci USA 1999; 96: 214\u2013219.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2015208_CR28","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1038\/leu.2014.81","volume":"28","author":"SL Locatelli","year":"2014","unstructured":"Locatelli SL, Cleris L, Stirparo GG, Tartari S, Saba E, Pierdominici M et al. BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts. Leukemia 2014; 28: 1861\u20131871.","journal-title":"Leukemia"},{"key":"BFcddis2015208_CR29","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cell.2013.03.022","volume":"153","author":"FJ Roca","year":"2013","unstructured":"Roca FJ, Ramakrishnan L . TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species. Cell 2013; 153: 521\u2013534.","journal-title":"Cell"},{"key":"BFcddis2015208_CR30","doi-asserted-by":"publisher","first-page":"16677","DOI":"10.1073\/pnas.0808597105","volume":"105","author":"BD Bell","year":"2008","unstructured":"Bell BD, Leverrier S, Weist BM, Newton RH, Arechiga AF, Luhrs KA et al. FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proc Natl Acad Sci USA 2008; 105: 16677\u201316682.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2015208_CR31","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/cdd.2012.90","volume":"19","author":"S Jouan-Lanhouet","year":"2012","unstructured":"Jouan-Lanhouet S, Arshad MI, Piquet-Pellorce C, Martin-Chouly C, Le Moigne-Muller G, Van Herreweghe F et al. TRAIL induces necroptosis involving RIPK1\/RIPK3-dependent PARP-1 activation. Cell Death Differ 2012; 19: 2003\u20132014.","journal-title":"Cell Death Differ"},{"key":"BFcddis2015208_CR32","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1158\/1078-0432.CCR-05-1036","volume":"12","author":"Z Lu","year":"2006","unstructured":"Lu Z, Luo RZ, Peng H, Rosen DG, Atkinson EN, Warneke C et al. Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer. Clin Cancer Res 2006; 12: 2404\u20132413.","journal-title":"Clin Cancer Res"},{"key":"BFcddis2015208_CR33","first-page":"4174","volume":"63","author":"J Yuan","year":"2003","unstructured":"Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M et al. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Cancer Res 2003; 63: 4174\u20134180.","journal-title":"Cancer Res"},{"key":"BFcddis2015208_CR34","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/82732","volume":"1","author":"N Holler","year":"2000","unstructured":"Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000; 1: 489\u2013495.","journal-title":"Nat Immunol"},{"key":"BFcddis2015208_CR35","doi-asserted-by":"publisher","first-page":"6057","DOI":"10.1182\/blood-2011-06-359448","volume":"118","author":"Y Xiao","year":"2011","unstructured":"Xiao Y, Li H, Zhang J, Volk A, Zhang S, Wei W et al. TNF-alpha\/Fas-RIP-1-induced cell death signaling separates murine hematopoietic stem cells\/progenitors into 2 distinct populations. Blood 2011; 118: 6057\u20136067.","journal-title":"Blood"},{"key":"BFcddis2015208_CR36","first-page":"7264","volume":"62","author":"JJ Bao","year":"2002","unstructured":"Bao JJ, Le XF, Wang RY, Yuan J, Wang L, Atkinson EN et al. Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway. Cancer Res 2002; 62: 7264\u20137272.","journal-title":"Cancer Res"},{"key":"BFcddis2015208_CR37","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/IGC.0000000000000065","volume":"24","author":"J Li","year":"2014","unstructured":"Li J, Cui G, Sun L, Wang SJ, Tian S, Guan Z et al. ARHI overexpression induces epithelial ovarian cancer cell apoptosis and excessive autophagy. Int J Gynecol Cancer 2014; 24: 437\u2013443.","journal-title":"Int J Gynecol Cancer"},{"key":"BFcddis2015208_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/cas.12351","volume":"105","author":"TQ Yang","year":"2014","unstructured":"Yang TQ, Lu XJ, Wu TF, Ding DD, Zhao ZH, Chen GL et al. MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-kappaB1\/MMP9 signaling pathway. Cancer Sci 2014; 105: 265\u2013271.","journal-title":"Cancer Sci"},{"key":"BFcddis2015208_CR39","doi-asserted-by":"publisher","first-page":"953203","DOI":"10.1155\/2014\/953203","volume":"2014","author":"M Gryko","year":"2014","unstructured":"Gryko M, Pryczynicz A, Zareba K, Kedra B, Kemona A, Guzinska-Ustymowicz K . The expression of Bcl-2 and BID in gastric cancer cells. J Immunol Res 2014; 2014: 953203.","journal-title":"J Immunol Res"},{"key":"BFcddis2015208_CR40","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.canlet.2014.04.021","volume":"351","author":"U Heinicke","year":"2014","unstructured":"Heinicke U, Fulda S . Chemosensitization of rhabdomyosarcoma cells by the histone deacetylase inhibitor SAHA. Cancer Lett 2014; 351: 50\u201358.","journal-title":"Cancer Lett"},{"key":"BFcddis2015208_CR41","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1182\/blood-2002-04-1174","volume":"100","author":"IM Pedersen","year":"2002","unstructured":"Pedersen IM, Kitada S, Schimmer A, Kim Y, Zapata JM, Charboneau L et al. The triterpenoid CDDO induces apoptosis in refractory CLL B cells. Blood 2002; 100: 2965\u20132972.","journal-title":"Blood"},{"key":"BFcddis2015208_CR42","doi-asserted-by":"publisher","first-page":"15540","DOI":"10.1073\/pnas.0607518103","volume":"103","author":"W Xu","year":"2006","unstructured":"Xu W, Ngo L, Perez G, Dokmanovic M, Marks PA . Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor. Proc Natl Acad Sci USA 2006; 103: 15540\u201315545.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2015208_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/boc.201200030","volume":"105","author":"M Klingauf","year":"2013","unstructured":"Klingauf M, Beck M, Berge U, Turgay Y, Heinzer S, Horvath P et al. The tumour suppressor DiRas3 interacts with C-RAF and downregulates MEK activity to restrict cell migration. Biol Cell 2013; 105: 91\u2013107.","journal-title":"Biol Cell"},{"key":"BFcddis2015208_CR44","doi-asserted-by":"publisher","first-page":"e1099","DOI":"10.1038\/cddis.2014.64","volume":"5","author":"J Ma","year":"2014","unstructured":"Ma J, Wan J, Meng J, Banerjee S, Ramakrishnan S, Roy S . Methamphetamine induces autophagy as a pro-survival response against apoptotic endothelial cell death through the Kappa opioid receptor. Cell Death Dis 2014; 5: e1099.","journal-title":"Cell Death Dis"},{"key":"BFcddis2015208_CR45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/2213988501408010003","volume":"8","author":"JV Peppard","year":"2014","unstructured":"Peppard JV, Rugg C, Smicker M, Dureuil C, Ronan B, Flamand O et al. Identifying small molecules which inhibit autophagy: a phenotypic screen using image-based high-content cell analysis. Curr Chem Genom Transl Med 2014; 8: 3\u201315.","journal-title":"Curr Chem Genom Transl Med"},{"key":"BFcddis2015208_CR46","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1158\/1940-6207.CAPR-10-0167","volume":"4","author":"Y Chen","year":"2011","unstructured":"Chen Y, Zaman MS, Deng G, Majid S, Saini S, Liu J et al. MicroRNAs 221\/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prev Res (Phila) 2011; 4: 76\u201386.","journal-title":"Cancer Prev Res (Phila)"},{"key":"BFcddis2015208_CR47","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1593\/neo.06838","volume":"9","author":"I Dalai","year":"2007","unstructured":"Dalai I, Missiaglia E, Barbi S, Butturini G, Doglioni C, Falconi M et al. Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors. Neoplasia 2007; 9: 181\u2013183.","journal-title":"Neoplasia"},{"key":"BFcddis2015208_CR48","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1210\/jc.2004-1447","volume":"90","author":"F Weber","year":"2005","unstructured":"Weber F, Aldred MA, Morrison CD, Plass C, Frilling A, Broelsch CE et al. Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis. J Clin Endocrinol Metab 2005; 90: 1149\u20131155.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFcddis2015208_CR49","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/mc.20461","volume":"48","author":"J Huang","year":"2009","unstructured":"Huang J, Lin Y, Li L, Qing D, Teng XM, Zhang YL et al. ARHI, as a novel suppressor of cell growth and downregulated in human hepatocellular carcinoma, could contribute to hepatocarcinogenesis. Mol Carcinog 2009; 48: 130\u2013140.","journal-title":"Mol Carcinog"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis2015208.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2015208","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2015208.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T10:09:29Z","timestamp":1672913369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2015208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,6]]},"references-count":49,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8]]}},"alternative-id":["BFcddis2015208"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2015.208","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,6]]},"assertion":[{"value":"24 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}